Global Orally Disintegrating Tablet Excipient Competitive Landscape Professional Research Report 2024

Global Orally Disintegrating Tablet Excipient Competitive Landscape Professional Research Report 2024

Research Summary

Orally disintegrating tablet (ODT) excipients are an essential component of ODT formulations. They are non-active ingredients added to ODTs to provide various functions, such as improving the tablet＇s taste, enhancing its disintegration properties, ensuring stability, and facilitating manufacturing processes. Common ODT excipients include superdisintegrants like crospovidone or croscarmellose sodium, which aid in the tablet＇s rapid dissolution in saliva, as well as sweeteners, flavors, and colorants to make the tablet more palatable. In addition, binding agents, fillers, and lubricants are used to ensure tablet integrity and assist in the manufacturing process. ODT excipients are carefully selected to achieve the desired balance of taste, texture, and performance, allowing for a convenient and effective delivery of medications that dissolve quickly in the mouth without the need for water.

According to DIResearch's in-depth investigation and research, the global Orally Disintegrating Tablet Excipient market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Orally Disintegrating Tablet Excipient include BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Merck, Ashland, Meggle Pharma, Evonik, Shin-Etsu, Fuji Chemical Industries, McePharma, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Orally Disintegrating Tablet Excipient. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Orally Disintegrating Tablet Excipient market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Orally Disintegrating Tablet Excipient market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Orally Disintegrating Tablet Excipient industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Orally Disintegrating Tablet Excipient Include:

BASF

JRS Pharma

Roquette

ABF Ingredients

DFE Pharma

Merck

Ashland

Meggle Pharma

Evonik

Shin-Etsu

Fuji Chemical Industries

McePharma

Cargill Incorporated

Daicel Corporation

Anhui Sunhere Pharmaceutical

Orally Disintegrating Tablet Excipient Product Segment Include:

Binders

Glidents

Diluents

Disintegrants

Others

Orally Disintegrating Tablet Excipient Product Application Include:

Anti-Psychotics Drug

Anti-Epileptics Drug

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Orally Disintegrating Tablet Excipient Industry PESTEL Analysis

Chapter 3: Global Orally Disintegrating Tablet Excipient Industry Porter’s Five Forces Analysis

Chapter 4: Global Orally Disintegrating Tablet Excipient Major Regional Market Size and Forecast Analysis

Chapter 5: Global Orally Disintegrating Tablet Excipient Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Orally Disintegrating Tablet Excipient Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources